Professional Documents
Culture Documents
MSD TENDER NUMBERS CLOSING ON 18/02/2020 at 10.00 Am: Tender No Item Quantit Y Pack Size Delivery
MSD TENDER NUMBERS CLOSING ON 18/02/2020 at 10.00 Am: Tender No Item Quantit Y Pack Size Delivery
00 am
TENDER NO ITEM QUANTIT PACK DELIVERY
Y SIZE
LP/MSD/CPU- MSD O/L No 2019/SPC/O/C/P/00166 6 1 vial IMMEDIATELY
DHS/NRQ/832/ SR No 01208601 VIALS with 15 months
(T)/2019 Residual Shelf
Item Cabazitaxel Inj. 60 mg /1.5ml vial
Specification Cabazitaxel Injection 60 mg / 1.5 ml vial with solvent. Life
Each 1.5ml vial to contain 60mg of Cabazitaxel for solution
for infusion.
Note:
01. This injection should be stable for a minimum of 24
months when stored at a temperature below 30 C
02. Each Vial should be labeled accordingly.
LP/MSD/CPU- MSD O/L No 2019/SPC/L/R/P/00456 5,300 25 Tabs IMMEDIATELY
DHS/RQ/833/ SR No 01200201 TABS in a box with 12 months
(T)/2019 Residual Shelf
Item Chlorambucil tablet 2mg
Specification Chlorambucil Tablets BP Life
Each coated tablet to contain 2mg of Chlorambucil BP
Note:
1.The tablet should be stable for a minimum of 24
months when stored within temperature range of
2'C - 8'C
TENDER NO ITEM QUANTITY PACK DELIVERY
SIZE
LP/MSD/CPU- MSD O/L No 2019/SPC/L/R/P/00865 1,400 10 VIALS IMMEDIATELY
DHS/RQ/834/ SR No 00205201 VIALS with 12 months
(E)/2019 Residual Shelf
Item Protamine sulphate inj50mg/5ml
Specification Protamine Sulphate injection BP 50mg/5ml. Life
Each 5ml ampoule to contain 50mg of Protamine Sulphate
BP in water for injection BP/USP for intravenous injection
OR
Protamine Sulfate injection USP 50mg/5ml
Each 5ml ampoule to contain 50mg of Protamine Sulphate
USP in water for injection BP/USP for intravenous injection
OR
Protamine Sulfate for injection USP 50mg/5ml.
Each 5ml ampoule to contain 50mg of Protamine Sulfate
USP as sterile dry powder with suitable dry diluents for
reconstitution with suitable solvent before use for
intravenous injection.
Note:
1.This injection should be stable for a minimum of 24
months when stored within the temperature range of
2C - 8C.
2.Sufficient overage to be added to the adequate shelf
life.
3.Each ampoule should be labelled accordingly.
TENDER NO ITEM QUANTITY PACK DELIVERY
SIZE
LP/MSD/CPU- MSD O/L No 2019/SPC/O/C/P/00774 2,716 01 VIAL 1,500 VIALS -
DHS/RQ/835/ SR No 01202901 Vials IMMEDIATELY &
(E)/2019 1,216 VIALS BY
Item Bevacizumab inj. 100mg/4mlvial
Specification Bevacizumab Injection 100mg/4ml 28/02/20 with 15
Each 4ml vial to contain 100mg of Bevacizumab for months Residual
intravenous infusion. Shelf Life
Note :
1.The product should be stable for a minimum of 24
months when stored within a
temperature range of 2'C-8'C.
2.Each vial should be labelled accordingly.
LP/MSD/CPU- MSD O/L No 2020/SPC/O/C/P/00159 7,915 01 Tab 4,000 TABS -
DHS/RQ/011/ SR No 01209901 TABS IMMEDIATELY &
(T)/2020 3,915 TABS -
Item Osimertinib tablet 80 mg
Specification Osimertinib (as mesylate) film-coated tablet 80 mg 28/02/2020 with
Each tablet to contain 80 mg of osimertinib as mesylate. 15 months
Note: Residual Shelf
01.The shelf life of the product should be minimum of 24 Life
months.
LP/MSD/CPU- MSD O/L No 2020/SPC/O/C/P/00162 900 01 VIAL 500 VIALS -
DHS/RQ/012/ SR No 01205102 VIALS IMMEDIATELY &
(E)/2020 400 VIALS -
Item Trastuzumab injection 440mgvial
Specification Trastuzumab injection 440mg with solvent in 20ml vial 28/02/20 with 15
Each 20ml vial to contain 440 mg of Trastuzumab with months Residual
suitable solvent for Shelf Life
intravenous use
Note:
1. The product should be stored at 2-8'C
2. Each vial should be labelled accordingly
3. The shelf life of the product should be minimum of 24
months
TENDER NO ITEM QUANTITY PACK DELIVERY
SIZE
LP/MSD/CPU- MSD O/L No 2020/SPC/O/C/P/00161 31,620 01 CAP 20,000 CAPS -
DHS/RQ/013/ SR No 01211701 CAPS IMMEDIATELY &
(T)/2020 11,620 CAPS -
Item Enzalutamide capsule 40mg
Specification Enzalutamide capsule 40mg 28/02/20 with 15
months Residual
Shelf Life
LP/MSD/CPU- MSD O/L No 2020/SPC/O/C/P/00155 96 01 VIAL IMMEDIATELY
DHS/RQ/014/ SR No 01211601 VIALS with 15 months
(E)/2020 Residual Shelf
Item Eribulin Mesylate Injection 1mg/2ml vial
Specification Eribulin Mesylate Injection 1mg/2ml vial Life
LP/MSD/CPU- MSD O/L No 2020/SPC/O/C/P/00157 1,014 01 vial 600 VIALS -
DHS/NRQ/015/ SR No 01203101 VIALS IMMEDIATELY
(T)/2020 & 414 VIALS BY
Item Cetuximab injection 100mg vial
Specification Cetuximab injection 5mg/ml, 20ml vial 28/02/20 with 15
Each 20ml vial to contain 5 mg/ml of Cetuximab, solution months Residual
for infusion Shelf Life
Note;
1. This injection should be stable for a minimum of 24
months when stored at a temperature range of 2'C-8'C
2. Each vial should be labeled accordingly.
LP/MSD/CPU- MSD O/L No 2020/SPC/O/C/P/00160 101 01 VIAL 60 VIALS -
DHS/RQ/016/ SR No 01210901 VIALS IMMEDIATELY &
(E)/2020 41 VIALS
Item Pertuzumab injection 420mg/14 ml vial
Specification Pertuzumab injection 30mg/ml 14ml vial 28/02/20 with 15
Each vial of concentrate to contain Pertuzumab at a months Residual
concentration of 30 mg/ml 14mlvial Shelf Life
Note:
1.This injection should be stable for a minimum of 24
months when stored within temperature of 2?C ? 8?C.
2.Each vial should be labelled accordingly.
TENDER NO ITEM QUANTITY PACK DELIVERY
SIZE
LP/MSD/CPU- MSD O/L No 2020/SPC/O/C/P/00149 7,899 01 cap 5,000 CAPS -
DHS/NRQ/017/ SR No 01209501 CAPS IMMEDIATELY &
(T)/2020 2,899 CAPS
Item Tretinoin Capsule 10mg
Specification Tretinoin Capsule 10mg 28/02/20 with 15
Each capsule to contain 10 mg of tretinoin BP/USP months Residual
Note: Shelf Life
01.The shelf life of the product should be minimum of 24
months.
conditions to the Tender
UUJHYou are requested to indicate the lowest price in Sri Lankan Rupees that could be afforded.
A Certified copy of the National Medicines Regulation Authority (NMRA – Sri Lanka) Registration Certificate, Certificate of Analysis (COA) should be
forwarded along with the quotation.
Your quotation / quotations shall be placed in the relevant tender box; which is placed in the Internal Audit Department of the Head Office of the State
Pharmaceuticals Corporation. prior to closing date and time indicated above. (Any late delivered / submitted bids will be rejected without accepting)
Tender Samples, with clear indication of the Tender No, shall be handed over to the Administration Department on or before the closing of tender and
acknowledgement of such samples should be attached to the quotation (bid).
SPC reserves the right to call samples from bidders who have not submitted samples before closing of the tender in cases of none of the bidders had submitted
samples, evaluators are with the opinion of calling samples from bidders who have not submitted samples and / or the Procurement committee is with the
opinion of calling of samples from the bidders who have not submitted samples will help them to make a cost effective decision.
Note
1. Please indicate the current market whole sale and Retail prices in your quotation (bid)
2. Your Quotation (bid) shall be submitted in one original and one duplicate, sealed separately and marked as “ORIGINAL” and “DUPLICATE” respectively.
Both envelopes shall be enclosed in one envelop and deposited in the tender box kept in the Internal Audit Department.
3. In case if the supplier / manufacturer is not registered with NMRA – Sri Lanka, please provide following details together with the bid (Quotation)
i) GMP certificate
ii) Certificate of Pharmaceutical Products
iii) Manufacturer’s information letter
iv) Certificate of Analysis of the Product